AAAAAA

   
Results: 1-14 |
Results: 14
QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA
Authors: MONTEROJULIAN FA RAMANANARIVO T TARTOUR E BRAILLY H
Citation: Fa. Monterojulian et al., QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA, European cytokine network, 9(3), 1998, pp. 286-286
MOLECULAR MODELING AND EXPLORATION OF THE SURFACE OF THE RHIL-6 DIMER- IMPLICATIONS FOR THE HIL-6 RECEPTOR COMPLEX ASSEMBLY
Authors: MONTEROJULIAN FA KALAI M CONTENT J WOLLMER A BRAILLY H GROTZINGER J
Citation: Fa. Monterojulian et al., MOLECULAR MODELING AND EXPLORATION OF THE SURFACE OF THE RHIL-6 DIMER- IMPLICATIONS FOR THE HIL-6 RECEPTOR COMPLEX ASSEMBLY, European cytokine network, 9(3), 1998, pp. 343-343
CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY
Authors: MONTEROJULIAN FA BRAILLY H SAUTES C JOYEUX I DORVAL T MOSSERI V YASUKAWA K WIJDENES J ADLER A GORIN I FRIDMAN WH TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
ANALYSIS OF THE MECHANISM OF ACTION OF ANTI-HUMAN INTERLEUKIN-6 AND ANTI-HUMAN INTERLEUKIN-6 RECEPTOR-NEUTRALIZING MONOCLONAL-ANTIBODIES
Authors: KALAI M MONTEROJULIAN FA BRAKENHOFF JPJ FONTAINE V DEWIT L WOLLMER A BRAILLY H CONTENT J GROTZINGER J
Citation: M. Kalai et al., ANALYSIS OF THE MECHANISM OF ACTION OF ANTI-HUMAN INTERLEUKIN-6 AND ANTI-HUMAN INTERLEUKIN-6 RECEPTOR-NEUTRALIZING MONOCLONAL-ANTIBODIES, European journal of biochemistry, 249(3), 1997, pp. 690-700
ANALYSIS OF THE HUMAN INTERLEUKIN-6 HUMAN INTERLEUKIN-6 RECEPTOR-BINDING INTERFACE AT THE AMINO-ACID LEVEL - PROPOSED MECHANISM OF INTERACTION
Authors: KALAI M MONTEROJULIAN FA GROTZINGER J FONTAINE V VANDENBUSSCHE P DESCHUYTENEER R WOLLMER A BRAILLY H CONTENT J
Citation: M. Kalai et al., ANALYSIS OF THE HUMAN INTERLEUKIN-6 HUMAN INTERLEUKIN-6 RECEPTOR-BINDING INTERFACE AT THE AMINO-ACID LEVEL - PROPOSED MECHANISM OF INTERACTION, Blood, 89(4), 1997, pp. 1319-1333
THE IL-6 IL-6R BINDING INTERFACE - PROPOSED MECHANISM OF INTERACTION/
Authors: KALAI M MONTEROJULIAN FA GROTZINGER J FONTAINE V VANDENBUSSCHE P DESCHUYTENEER R WOLLMER A BRAILLY H CONTENT J
Citation: M. Kalai et al., THE IL-6 IL-6R BINDING INTERFACE - PROPOSED MECHANISM OF INTERACTION/, Archives of physiology and biochemistry, 104(3), 1996, pp. 43-43
REQUIREMENT OF PHOSPHATIDYLINOSITOL-3 KINASE FOR EPITHELIAL-CELL MIGRATION ACTIVATED BY HUMAN MACROPHAGE STIMULATING PROTEIN
Authors: WANG MH MONTEROJULIAN FA DAUNY I LEONARD EJ
Citation: Mh. Wang et al., REQUIREMENT OF PHOSPHATIDYLINOSITOL-3 KINASE FOR EPITHELIAL-CELL MIGRATION ACTIVATED BY HUMAN MACROPHAGE STIMULATING PROTEIN, Oncogene, 13(10), 1996, pp. 2167-2175
PARTICIPATION OF 2 SER-SER-PHE-TYR REPEATS IN INTERLEUKIN-6 (IL-6)-BINDING SITES OF THE HUMAN IL-6 RECEPTOR
Authors: KALAI M MONTEROJULIAN FA GROTZINGER J WOLLMER A MORELLE D BROCHIER J ROSEJOHN S HEINRICH PC BRAILLY H CONTENT J
Citation: M. Kalai et al., PARTICIPATION OF 2 SER-SER-PHE-TYR REPEATS IN INTERLEUKIN-6 (IL-6)-BINDING SITES OF THE HUMAN IL-6 RECEPTOR, European journal of biochemistry, 238(3), 1996, pp. 714-723
PHARMACOKINETIC STUDY OF ANTI-INTERLEUKIN-6 (IL-6) THERAPY WITH MONOCLONAL-ANTIBODIES - ENHANCEMENT OF IL-6 CLEARANCE BY COCKTAILS OF ANTI-IL-6 ANTIBODIES
Authors: MONTEROJULIAN FA KLEIN B GAUTHEROT E BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETIC STUDY OF ANTI-INTERLEUKIN-6 (IL-6) THERAPY WITH MONOCLONAL-ANTIBODIES - ENHANCEMENT OF IL-6 CLEARANCE BY COCKTAILS OF ANTI-IL-6 ANTIBODIES, Blood, 85(4), 1995, pp. 917-924
PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES
Authors: MONTEROJULIAN FA GAUTHEROT E WIJDENES J KLEIN B BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES, Journal of interferon research, 14(5), 1994, pp. 301-302
PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES
Authors: MONTEROJULIAN FA GAUTHEROT E WIJDENES J KLEIN B BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES, Journal of interferon research, 14(5), 1994, pp. 301-302
IMMUNOASSAY FOR FUNCTIONAL HUMAN SOLUBLE INTERLEUKIN-6 RECEPTOR IN PLASMA BASED ON LIGAND RECEPTOR INTERACTIONS/
Authors: MONTEROJULIAN FA LIAUTARD J FLAVETTA S ROMAGNE F GAILLARD JP BROCHIER J KLEIN B BRAILLY H
Citation: Fa. Monterojulian et al., IMMUNOASSAY FOR FUNCTIONAL HUMAN SOLUBLE INTERLEUKIN-6 RECEPTOR IN PLASMA BASED ON LIGAND RECEPTOR INTERACTIONS/, Journal of immunological methods, 169(1), 1994, pp. 111-121
TOTAL INTERLEUKIN-6 IN PLASMA MEASURED BY IMMUNOASSAY
Authors: BRAILLY H MONTEROJULIAN FA ZUBER CE FLAVETTA S GRASSI J HOUSSIAU F VANSNICK J
Citation: H. Brailly et al., TOTAL INTERLEUKIN-6 IN PLASMA MEASURED BY IMMUNOASSAY, Clinical chemistry, 40(1), 1994, pp. 116-123
TARGETING OF INTERLEUKIN-2 TO THE PERIPLASM OF ESCHERICHIA-COLI
Authors: HALFMANN G BRAILLY H BERNADAC A MONTEROJULIAN FA LAZDUNSKI C BATY D
Citation: G. Halfmann et al., TARGETING OF INTERLEUKIN-2 TO THE PERIPLASM OF ESCHERICHIA-COLI, Journal of General Microbiology, 139, 1993, pp. 2465-2473
Risultati: 1-14 |